| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/06/2010 | CA2150785C Conjugates of methyltrithio antitumor agents and intermediates for their synthesis |
| 07/01/2010 | WO2010075418A2 Glyceollins suppress androgen-responsive prostate cancer |
| 07/01/2010 | WO2010075255A2 Methods for treating or preventing cancer and neurodegenerative diseases |
| 07/01/2010 | WO2010075086A2 Pyrrolidinone inhibitors of pde-4 |
| 07/01/2010 | WO2010075074A1 Protein kinase inhibitors |
| 07/01/2010 | WO2010075072A2 Long circulating nanoparticles for sustained release of therapeutic agents |
| 07/01/2010 | WO2010075069A1 Bicyclic pyranone derivatives as nicotinic acid receptor agonists |
| 07/01/2010 | WO2010075060A2 Methods and compositions for modulating proline levels |
| 07/01/2010 | WO2010074662A1 Antitumor agent, a method for the production of said agent and a method for the stabilisation thereof |
| 07/01/2010 | WO2010074586A1 Pyrazolo[1,5-a]pyridine and imidazo[1,2-a]pyridine derivatives and their use in cancer therapy |
| 07/01/2010 | WO2010074553A1 Anti-cancer nutraceutical composition |
| 07/01/2010 | WO2010074541A2 Drug delivery carrier using zz domain |
| 07/01/2010 | WO2010074284A1 Pyrazolopyrimidine compound |
| 07/01/2010 | WO2010074266A1 Anti-cd4 antibody |
| 07/01/2010 | WO2010074241A1 Method for predicting therapeutic effect of combination chemotherapy |
| 07/01/2010 | WO2010074240A1 Method for predicting therapeutic effect of chemotherapy |
| 07/01/2010 | WO2010074220A1 Composition containing sesamins and epigallocatechin gallate |
| 07/01/2010 | WO2010074218A1 Anti-human midkine antibody |
| 07/01/2010 | WO2010074192A1 Diagnosis and treatment of cancer using anti-lgr7 antibody |
| 07/01/2010 | WO2010074089A1 Indanyl compounds |
| 07/01/2010 | WO2010074088A1 Cyclic amine compounds |
| 07/01/2010 | WO2010074082A1 Modified vasohibin |
| 07/01/2010 | WO2010074049A1 Anti-hs6st2 antibody and use thereof |
| 07/01/2010 | WO2010073721A1 Prediction of effectiveness of preoperative chemoradiotherapy on rectal cancer using micro-rna |
| 07/01/2010 | WO2010073719A1 Eg5 inhibitor |
| 07/01/2010 | WO2010073694A1 Diagnosis of treatment of cancer using anti-tm4sf20 antibody |
| 07/01/2010 | WO2010073642A1 Bioactive agent, pharmaceutical product, cosmetic product, freshness keeping agent, and plant and animal growth promoting agent |
| 07/01/2010 | WO2010073551A1 C1orf59 peptides and vaccines including the same |
| 07/01/2010 | WO2010073235A1 Ppar agonist compositions and methods of use |
| 07/01/2010 | WO2010073126A2 Compounds useful in delivering anti-neoplastic therapy and diagnostic imaging to hypoxic cells and methods of use thereof |
| 07/01/2010 | WO2010073043A1 Immunogenic composition and use thereof |
| 07/01/2010 | WO2010073034A1 Pyrimidine indole derivatives for treating cancer |
| 07/01/2010 | WO2010073011A2 Compounds useful as medicaments |
| 07/01/2010 | WO2010072843A2 Use of a peptide derived from er-alpha for restoring sensitivity to antiestrogenic compounds in breast tumour cells |
| 07/01/2010 | WO2010072823A1 PYRAZOLE[1,5a]PYRIDINE DERIVATIVES |
| 07/01/2010 | WO2010072770A2 Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering |
| 07/01/2010 | WO2010072754A1 HYDROSOLUBLE [6)O-α-D-GLCP-(1→]n-6-O-β-D-GLCP-(1→-PHENOLIC DERIVATIVES WITH DERMOCOSMETIC, NUTRITIONAL AND THERAPEUTIC APPLICATIONS, AND COMPOSITIONS CONTAINING SAID WATER SOLUBLE COMPOUNDS |
| 07/01/2010 | WO2010072743A1 Immunostimulating saponins for use in in situ tumor-destruction therapy |
| 07/01/2010 | WO2010072741A1 TARGETED BINDING AGENTS DIRECTED TO α5β1 AND USES THEREFOR |
| 07/01/2010 | WO2010072740A2 TARGETED BINDING AGENTS DIRECTED TO α5β1 AND USES THEREOF |
| 07/01/2010 | WO2010072734A2 Targeting prodrugs and compositions for the treatment of gastrointestinal diseases |
| 07/01/2010 | WO2010072684A1 Norrin in the treatment of diseases associated with an increased tgf-beta activity |
| 07/01/2010 | WO2010072399A1 7-azaindirubins, 7'azaindirubins, 7,7'-diazaindirubins and the corresponding 3'-oxime ether derivatives thereof, their production and use as a medicament |
| 07/01/2010 | WO2010072352A1 1, 2, 4 -oxadiazole derivatives and their therapeutic use |
| 07/01/2010 | WO2010072301A1 3-(3-pyrimidine-2-yl-benzyl)-[1,2,4] triazolo [4,3-b] pyridazine derivatives |
| 07/01/2010 | WO2010072296A1 Pyridazinone derivatives |
| 07/01/2010 | WO2010072295A1 Novel polymorphic forms of 6-(1-methyl-1h-pyrazol-4-yl)-2-{3-[5-(2-morpholin-4-yl-ethoxy)-pyrimidin-2-yl]-benzyl}-2h-pyridazin-3-one dihydrogenphosphate and processes of manufacturing thereof |
| 07/01/2010 | WO2010072166A1 Preparation method of dihydroindene amide compounds,their pharmaceutical compositions containg compounds thereof and use as protein kinases inhibitor |
| 07/01/2010 | WO2010072109A1 A sustained release system for tumor treating medicament |
| 07/01/2010 | WO2010072018A1 Crosslink dextran magnetic complex microparticles and the preparation method and using method thereof |
| 07/01/2010 | WO2010071941A1 Plant extracts from acronychia species and their use |
| 07/01/2010 | WO2010054024A3 1, 2 -thiazol yl derivatives as cannabinoid receptor ligands |
| 07/01/2010 | WO2010045395A3 Curcumin analog compositions and related methods |
| 07/01/2010 | WO2010037864A3 Inhibition of plgf to treat philadelphia chromosome positive leukemia |
| 07/01/2010 | WO2010036567A3 Harmine compounds for promoting bone growth |
| 07/01/2010 | WO2010033980A3 4-azaindole bisphosphonates |
| 07/01/2010 | WO2010033978A3 IMIDAZO[1,2-α ]PYRIDINYL BISPHOSPHONATES |
| 07/01/2010 | WO2010033678A3 Novel method and application of unsymmetrically meso-substituted porphyrins and chlorins for pdt |
| 07/01/2010 | WO2010033580A3 Curcumin conjugates for treating and preventing cancers |
| 07/01/2010 | WO2010030983A3 Pyrazole carboxamide inhibitors of factor xa |
| 07/01/2010 | WO2010030980A3 Akt and clusterin as biomarkers of chemotherapeutic responsiveness |
| 07/01/2010 | WO2010028187A3 Methods and compositions for the treatment of cancer |
| 07/01/2010 | WO2010025138A3 Pyrimidine compounds |
| 07/01/2010 | WO2010024930A3 Cortistatin analogues and syntheses therof |
| 07/01/2010 | WO2010022089A3 Derivatives of apf and methods of use |
| 07/01/2010 | WO2010021693A3 Mif modulators |
| 07/01/2010 | WO2010005876A3 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/01/2010 | WO2010000851A3 Methods for modulating angiogenesis via dystrophin dp71 |
| 07/01/2010 | WO2009154739A3 Smoothened receptor modulators |
| 07/01/2010 | WO2009108388A8 Enzymatic production or chemical synthesis and uses for 5,7-dienes and uvb conversion products thereof |
| 07/01/2010 | US20100169995 Targeted gene disruptions in the iqgap2 gene |
| 07/01/2010 | US20100169992 Fgfr4 antibodies |
| 07/01/2010 | US20100168248 Process for producing enriched fractions of tetrahydroxycurcumin and tetrahydrotetrahdroxy-curcumin from the extracts of curcuma longa |
| 07/01/2010 | US20100168244 Naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them |
| 07/01/2010 | US20100168242 Polymorphs of suberoylanilide hydroxamic acid |
| 07/01/2010 | US20100168228 Novel chemotherapeutic agents against inflammation and cancer |
| 07/01/2010 | US20100168217 Sulfamatobenzothiophene derivatives |
| 07/01/2010 | US20100168214 Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer |
| 07/01/2010 | US20100168210 T-Cell Cytokine-Inducing Surface Molecules and Methods of Use |
| 07/01/2010 | US20100168207 Compositions and methods for sirna inhibition of angiogenesis |
| 07/01/2010 | US20100168206 GNAQ Targeted dsRNA Compositions And Methods For Inhibiting Expression |
| 07/01/2010 | US20100168202 Rad 9 as a diagnostic,prognostic,and therapeutic tool for prostate cancer |
| 07/01/2010 | US20100168199 Kinase Inhibitors |
| 07/01/2010 | US20100168184 Small molecule bcl-x1/bcl-2 binding inhibitors |
| 07/01/2010 | US20100168182 Compounds and compositions as kinase inhibitors |
| 07/01/2010 | US20100168180 Novel Compounds |
| 07/01/2010 | US20100168179 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations |
| 07/01/2010 | US20100168170 Piperidinones Useful in the Treatment of Inflammation |
| 07/01/2010 | US20100168169 Substituted 1,3-dioxanes useful as ppar modulators |
| 07/01/2010 | US20100168167 Piperidinones Useful in the Treatment of Inflammation |
| 07/01/2010 | US20100168163 Cyclic-alkylamine derivatives as inhibitors of the interaction between mdm2 and p53 |
| 07/01/2010 | US20100168162 Selective inhibitors of akt and methods of using same |
| 07/01/2010 | US20100168159 Hetero compound |
| 07/01/2010 | US20100168158 Modulators of cystic fibrosis transmembrane conductance regulator |
| 07/01/2010 | US20100168155 DERIVATIVES OF IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDES, PREPARATION METHOD THEREOF AND USE OF SAME IN THERAPEUTICS |
| 07/01/2010 | US20100168153 Salts and crystall forms of 2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-imidazo[4,5-c]quinolin-1-yl)-phenyl]-propionitrile |
| 07/01/2010 | US20100168150 Camptothecin Analogue Compounds, a Process for Their Preparation and Pharmaceutical Compositions Containing Them. |
| 07/01/2010 | US20100168149 Camptothecin Analogue Compounds, a Process for Their Preparation and Pharmaceutical Compositions Containing Them |
| 07/01/2010 | US20100168143 Quinazoline derivatives |
| 07/01/2010 | US20100168142 Salts of 4-aniline quinazoline derivative |